Page last updated: 2024-09-04

b-ht 958 and dihydroxyphenylalanine

b-ht 958 has been researched along with dihydroxyphenylalanine in 1 studies

*Dihydroxyphenylalanine: A beta-hydroxylated derivative of phenylalanine. The D-form of dihydroxyphenylalanine has less physiologic activity than the L-form and is commonly used experimentally to determine whether the pharmacological effects of LEVODOPA are stereospecific. [MeSH]

*Dihydroxyphenylalanine: A beta-hydroxylated derivative of phenylalanine. The D-form of dihydroxyphenylalanine has less physiologic activity than the L-form and is commonly used experimentally to determine whether the pharmacological effects of LEVODOPA are stereospecific. [MeSH]

Compound Research Comparison

Studies
(b-ht 958)
Trials
(b-ht 958)
Recent Studies (post-2010)
(b-ht 958)
Studies
(dihydroxyphenylalanine)
Trials
(dihydroxyphenylalanine)
Recent Studies (post-2010) (dihydroxyphenylalanine)
15038,823322833

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Andén, NE; Grabowska-Andén, M1

Other Studies

1 other study(ies) available for b-ht 958 and dihydroxyphenylalanine

ArticleYear
B-HT 958 stimulates dopamine autoreceptors but blocks noradrenaline autoreceptors in the brain.
    The Journal of pharmacy and pharmacology, 1984, Volume: 36, Issue:11

    Topics: Adrenergic alpha-Agonists; alpha-Methyltyrosine; Animals; Apomorphine; Azepines; Brain Chemistry; Clonidine; Dihydroxyphenylalanine; Dopamine; Haloperidol; Male; Methyltyrosines; Mice; Motor Activity; Norepinephrine; Receptors, Adrenergic; Receptors, Dopamine; Reserpine; Synapses

1984